Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
C-Rad
OM:CRAD B Community
Create a narrative
C-Rad
Undervalued
Overvalued
C-Rad
WA
Analyst Price Target
Consensus Narrative from 1 Analyst
Global Expansion And SGRT Demand Will Drive Future Success
Key Takeaways Strategic global expansion, particularly in APAC, and long-term contracts in advanced markets support revenue growth and market share increase. Strong order backlog and investment in innovation and SGRT position C-RAD for revenue acceleration and long-term profitability.
View narrative
SEK 47.00
FV
30.9% undervalued
intrinsic discount
15.84%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
CRAD B
C-Rad
Your Fair Value
SEK
Current Price
SEK 32.50
26.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-31m
820m
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 819.5m
Earnings SEK 98.7m
Advanced
Set as Fair Value